Advertisement

U.S. Markets open in 8 hrs 54 mins

S&P Futures
5,968.25
+10.00(+0.17%)
Dow Futures
44,007.00
+106.00(+0.24%)
Nasdaq Futures
20,933.50
+39.50(+0.19%)
Russell 2000 Futures
2,412.30
+6.50(+0.27%)
Crude Oil
72.03
+0.34(+0.47%)
Gold
2,665.00
-11.30(-0.42%)

Vincerx Pharma, Inc. (VINC)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD

0.3270

-0.0190

(-5.49%)

At close: 04:00PM EST

0.3414

+0.01

(+4.40%)

After hours:

07:25PM EST

Trade prices are not sourced from all markets

All

Zacks
What Makes Vincerx Pharma (VINC) a New Buy Stock
Vincerx Pharma (VINC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
- Community Financial (CBU) Upgraded to Buy: Here's What You Should Know
  Zacks
- Jackson Financial (JXN) Upgraded to Strong Buy: Here's What You Should Know
  Zacks
GlobeNewswire
Vincerx Reports Positive Initial Clinical Data from Ongoing VIP943 Phase 1 Dose-Escalation Study and Provides Pipeline and Corporate Updates
VIP943 demonstrates promising safety and tolerability and achieves two complete responses to date in Phase 1 dose-escalation study, reinforcing the program’s potential and validating the VersAptx™ Platform technology Vincerx focusing resources on continued development of VIP943 Expected cash runway into early 2025 Management to host webcast and Q&A today at 5:00 PM EDT to review pipeline and corporate updates, followed by commentary from key opinion leader Dr. M. Yair Levy PALO ALTO, Calif., Oct